Drug
Myo Inositol
Myo Inositol: highest development phase Post-Market, developed by Gedeon Richter. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Gedeon Richter
Trials
| Drug | Phase | Indication |
|---|---|---|
| Myo-inositol NCT04306692 | Post-Market | Ovulation Induction |
Latest
No recent events.
Follow Myo Inositol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.